BOESS CARSTEN

CIK 00012774958 companiesCRANBURY, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001277495

Recent Transactions

50 trades

Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2026-06-18+64,860→ 64,860 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2026-06-18+22,862→ 52,862 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−10,034→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-02-27−6,692→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−22,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−13,489→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−15,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−22,000→ 0 total
Award
Atrium Therapeutics, Inc.$RNA
Stock Option (Right to Buy)
2026-02-27+20,000→ 20,000 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−20,858→ 0 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Common Stock
2025-06-18+30,000→ 30,000 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-06-10+6,692→ 6,692 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-06-10+10,034→ 10,034 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2024-06-13+23,944→ 23,944 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-06-13+13,489→ 13,489 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2023-06-22+25,850→ 25,850 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2023-06-15+22,000→ 22,000 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2022-06-15+22,000→ 22,000 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2022-06-13+47,745→ 47,745 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2021-06-16+15,000→ 15,000 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2021-06-14+12,236→ 12,236 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2020-06-16+20,000→ 20,000 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2019-01-28+30,000→ 30,000 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class B Common Shares
2018-05-29+107,050→ 473,035 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Shares
2018-05-29+6,392→ 79,589 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Series C Preferred Shares
2018-05-29−6,392→ 0 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Series A Preferred Shares
2018-05-29−107,050→ 0 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Option (Right to Buy)
2018-03-29+40,000→ 40,000 total
Purchase
Kiniksa Pharmaceuticals International, plc$KNSA
Series C Preferred Shares
2018-02-09$15.64/sh+6,392→ 6,392 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Options (Right to Buy)
2017-06-20+45,000→ 45,000 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Options (Right to Buy)
2016-06-23+12,000→ 12,000 total
Award
ROCKET PHARMACEUTICALS, INC.$RCKT
Stock Options (Right to Buy)
2016-01-11+24,000→ 24,000 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Stock Options (Right to Buy)
2015-06-22−7,292→ 0 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-06-22−24,000→ 0 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Stock Options (Right to Buy)
2015-06-22−40,000→ 0 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Stock Options (Right to Buy)
2015-06-22−15,938→ 0 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Stock Options (Right to Buy)
2015-06-22−45,000→ 0 total
Disposition to Issuer
SYNAGEVA BIOPHARMA CORP
Stock Options (Right to Buy)
2015-06-22−9,929→ 0 total
Award
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-06-05+24,000→ 24,000 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy)
2015-02-17−29,062→ 15,938 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy)
2015-02-17−13,235→ 9,929 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-02-17$101.69/sh−1,842→ 0 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-02-17$100.74/sh−16,716→ 1,842 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-02-17$99.97/sh−14,750→ 18,558 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-02-17$98.85/sh−8,989→ 33,308 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-02-17$40.74/sh+29,062→ 42,297 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Common Stock
2015-02-17$1.70/sh+13,235→ 13,235 total
Sale
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-10-30$80.11/sh−22,904→ 0 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Common Stock
2014-10-30$23.00/sh+7,854→ 22,904 total
Exercise/Conversion
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy)
2014-10-30−7,854→ 7,292 total

BOESS CARSTEN

Recent Transactions

Companies

Recent Filings

Address